Blueprint Medicines
An Intern, Clinical Research role at Blueprint Medicines supports various research and development activities in clinical trials and scientific documentation.
Headquarters
Cambridge, Massachusetts, United States
Company Size
501-1000 employees
Founded
2011
Blueprint Medicines is a biotechnology company focused on developing targeted therapies for patients with cancer and rare diseases. The company uses precision medicine and genomics to design drugs that selectively inhibit disease-causing proteins, particularly kinase-driven cancers and systemic mastocytosis.
Sanofi To Buy Blueprint Medicines For Up To $9.5B: Retail Sees More Acquisition Offers From European Pharma Companies
4 days ago
Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis
2 weeks ago
Blueprint’s rare disease drug Ayvakit shows long-term benefit
1 week ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Blueprint Medicines.
Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover
Jun 2, 2025
UNIV - Research Instructor - Department of PHS
Medical University of South Carolina (MUSC)
Biostatistics Manager, General Medicine (U.S. - Remote)
Amgen
Data Science & Bioinformatics, Scientist
Crown Bioscience, Inc.
Assistant/Associate Professor - Biostatistics
Louisiana State University
Research Officer / Senior Research Officer
JobAps
Senior Biostatistician
Lexitas